Brief: CEPI, THSTI, Panacea Biotec Partner To Develop Broadly Protective Betacoronavirus Vaccines
21/02/2022 10:46
Feb 21 (Reuters) - Panacea Biotec Ltd PNCA.NS :
* CEPI, THSTI AND PANACEA BIOTEC PARTNER TO DEVELOP BROADLY
PROTECTIVE BETACORONAVIRUS VACCINES
Source text for Eikon: ID:nBSE5rJNKr
Further company coverage: PNCA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Panacea Biotec
See all newsBrief: Panacea Biotec Receives Letter Of Award For BOPV Supply Worth $8.205 Million
Brief: Panacea Biotec Unit Gets Show Cause Notice Alleging Total Tax Liability Of 40.6 Million Rupees
Brief: Panacea Biotec Files Appeal Against Fourth Industrial Tribunal (Mohali) Award
India's Panacea Biotec rises to record high on EU-backed dengue vaccine project
India Stocks: Indian shares rise as banks gain on RBI forex swap facility